SCHEMBL14447679

SCHEMBL14447679

O=c1c2ccccc2[nH]c2cc(N3CCOCC3)cc(OP(=O)(O)O)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
KMT2A Q03164 2/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KIF11 P52732 4/20 0.43
ABCG2 Q9UNQ0 3/20 0.42
APAF1 O14727 1/20 0.40
CDC25B P30305 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
PRKDC P78527 2/20 0.40
PIK3C3 Q8NEB9 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14802149 0.85 KDM4E (0.47) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL5801741 0.83 KIF11 (0.44) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL5801743 0.81 PRKDC (0.42) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL5440644 0.81 PRKDC (0.55) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL14447676 0.72 PRKDC (0.37) ALDH1A1MAPTL3MBTL1PRKDCBRAF
SCHEMBL14447677 0.71 PRKDC (0.48) PRKDC
SCHEMBL5459622 0.67 PRKDC (0.45) MAPTKIF11PRKDCBRAF
SCHEMBL14447675 0.67 PRKDC (0.49) ALDH1A1KDM4EMAPTHPGDPRKDC
SCHEMBL5442834 0.65 PRKDC (0.48) ALDH1A1KDM4EMEN1MAPTHPGD
Acridone SCHEMBL23458097 0.65 ALDH1A1 (0.67) ALDH1A1KDM4EMEN1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404681-B2 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors LUITPOLD PHARMACEUTICALS, INC. (US) 2013-03-26 US disclosed
US-8404681-B2 Xanthones, thioxanthones and acridinones as DNA-PK inhibitors LUITPOLD PHARMACEUTICALS, INC. (US) 2013-03-26 US disclosed
US-20070167441-A1 Xanthones, thioxanthones and acridinones as dna-pk inhibitors LUITPOLD PHARMACEUTICALS, INC. 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167441-A1 Xanthones, thioxanthones and acridinones as dna-pk inhibitors DCK, DTYMK, XPA ALDH1A1 3664/4885KDM4E 1348/4885MEN1 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.